Owlet, Inc. shares fall 1.23% intraday after launching medically-certified Dream Sock in South Africa.

Owlet, Inc. declined 1.23% in intraday trading, despite the company announcing the launch of its medically-certified Dream Sock in South Africa. The product, distributed as a Class C Medical Device with CE Marking, allows parents to track their baby's live vital signs and receive real-time health notifications. The product is designed for healthy babies between 0 and 18 months and is available at various retailers, including Baby City, Babies R Us, and Checkers.